Duke Medicine Timeline

- COVID-19 Research

DCRI receives a $50 million PCORI grant for the Healthcare Worker Exposure Response and Outcomes (HERO) research program and receives a $80 million NIH grant for RADx-UP, both research programs that will study the prevention and testing of COVID-19.

The National Institute of Allergy and Infectious Diseases (NIAID) also awards $17.5 million over three years to the Duke Human Vaccine Institute to develop a vaccine that protects against multiple types of coronaviruses and viral variants.